Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Catanzaro

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Scandinavian Journal of Urology|June 29, 2022
Renal tumor biopsy in patients with cT1b-T4-M0 disease susceptible to radical nephrectomy: analysis of safety, accuracy and clinical impact on definitive managementSebastiano Nazzani, Carlotta Zaborra, Davide Biasoni, et al.
Urologic Oncology|April 1, 2025
Organ preservation and oncological efficacy of peniscopically controlled CO<sub>2</sub> laser excision of penile squamous cell carcinoma: Early and late results in a high-volume centerSebastiano Nazzani, Vito Lorusso, Mario Catanzaro, et al.
The Journal of Urology|April 12, 2021
Clinical Outcomes in Clinical N0 Squamous Cell Carcinoma of the Penis According to Nodal Management: Early, Delayed or Selective (following Dynamic Sentinel Node Biopsy) Inguinal Lymph-Node DissectionSebastiano Nazzani, Mario Catanzaro, Davide Biasoni, et al.
Tumori|August 2, 2022
Retroperitoneal lymph-node dissection (RPLND) as upfront management in stage II germ-cell tumours: Evaluation of safety and efficacyNicola Nicolai, Sebastiano Nazzani, Antonio Tesone, et al.
Clinical Genitourinary Cancer|January 8, 2014
Long-term efficacy and safety outcomes of modified (simplified) MVAC (methotrexate/vinblastine/doxorubicin/cisplatin) as frontline therapy for unresectable or metastatic urothelial cancerAndrea Necchi, Luigi Mariani, Patrizia Giannatempo, et al.
The Journal of Urology|October 2, 2017
Laparoscopic Retroperitoneal Lymph Node Dissection for Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Safety and Efficacy Analyses at a High Volume CenterNicola Nicolai, Nicholas Tarabelloni, Francesca Gasperoni, et al.
Tumori|June 6, 2015
Quality of life and pain control following laparoscopic retroperitoneal lymph node dissection in early-stage nonseminomaNicola Nicolai, Elisabetta Bianchi, Ilaria Donati, et al.
Urologic Oncology|March 3, 2023
Bilateral inguinal lymph-node dissection vs. unilateral inguinal lymph-node dissection and dynamic sentinel node biopsy in clinical N1 squamous cell carcinoma of the penisSebastiano Nazzani, Mario Catanzaro, Davide Biasoni, et al.
Urologic Oncology|May 5, 2019
Nomogram-based prediction of overall survival after regional lymph node dissection and the role of perioperative chemotherapy in penile squamous cell carcinoma: A retrospective multicenter studyAndrea Necchi, Salvatore Lo Vullo, Luigi Mariani, et al.
Clinical Genitourinary Cancer|March 2, 2015
Clinical Outcomes of Metastatic Poor Prognosis Germ Cell Tumors: Current Perspective From a Referral CenterAndrea Necchi, Elena Farè, Salvatore Lo Vullo, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Scandinavian Journal of Urology|June 29, 2022
Renal tumor biopsy in patients with cT1b-T4-M0 disease susceptible to radical nephrectomy: analysis of safety, accuracy and clinical impact on definitive managementSebastiano Nazzani, Carlotta Zaborra, Davide Biasoni, et al.
Urologic Oncology|April 1, 2025
Organ preservation and oncological efficacy of peniscopically controlled CO<sub>2</sub> laser excision of penile squamous cell carcinoma: Early and late results in a high-volume centerSebastiano Nazzani, Vito Lorusso, Mario Catanzaro, et al.
The Journal of Urology|April 12, 2021
Clinical Outcomes in Clinical N0 Squamous Cell Carcinoma of the Penis According to Nodal Management: Early, Delayed or Selective (following Dynamic Sentinel Node Biopsy) Inguinal Lymph-Node DissectionSebastiano Nazzani, Mario Catanzaro, Davide Biasoni, et al.
Tumori|August 2, 2022
Retroperitoneal lymph-node dissection (RPLND) as upfront management in stage II germ-cell tumours: Evaluation of safety and efficacyNicola Nicolai, Sebastiano Nazzani, Antonio Tesone, et al.
Clinical Genitourinary Cancer|January 8, 2014
Long-term efficacy and safety outcomes of modified (simplified) MVAC (methotrexate/vinblastine/doxorubicin/cisplatin) as frontline therapy for unresectable or metastatic urothelial cancerAndrea Necchi, Luigi Mariani, Patrizia Giannatempo, et al.
The Journal of Urology|October 2, 2017
Laparoscopic Retroperitoneal Lymph Node Dissection for Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Safety and Efficacy Analyses at a High Volume CenterNicola Nicolai, Nicholas Tarabelloni, Francesca Gasperoni, et al.
Tumori|June 6, 2015
Quality of life and pain control following laparoscopic retroperitoneal lymph node dissection in early-stage nonseminomaNicola Nicolai, Elisabetta Bianchi, Ilaria Donati, et al.
Urologic Oncology|March 3, 2023
Bilateral inguinal lymph-node dissection vs. unilateral inguinal lymph-node dissection and dynamic sentinel node biopsy in clinical N1 squamous cell carcinoma of the penisSebastiano Nazzani, Mario Catanzaro, Davide Biasoni, et al.
Urologic Oncology|May 5, 2019
Nomogram-based prediction of overall survival after regional lymph node dissection and the role of perioperative chemotherapy in penile squamous cell carcinoma: A retrospective multicenter studyAndrea Necchi, Salvatore Lo Vullo, Luigi Mariani, et al.
Clinical Genitourinary Cancer|March 2, 2015
Clinical Outcomes of Metastatic Poor Prognosis Germ Cell Tumors: Current Perspective From a Referral CenterAndrea Necchi, Elena Farè, Salvatore Lo Vullo, et al.
Pageof 7